National Institutes for Food and Drug Control Researchers Have Provided New Study Findings on Collagen Type XVIII (Generation and utilization of endostatin-sensitive cell lines for assessing the biological activity of endostatin).

A new study conducted by researchers at the National Institutes for Food and Drug Control has provided findings on collagen type XVIII. The study focused on the biological activity of recombinant proteins, which are increasingly being used to treat human diseases. The researchers used gene-editing technology to identify potential endostatin-resistant genes and successfully constructed a highly sensitive cell line for detecting the biological activity of endostatin. The method was validated and produced consistent results with higher sensitivity and more stable data compared to traditional methods. This research provides a novel solution for assessing the biological activity of recombinant proteins. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)